AroCell Balance Sheet Health
Financial Health criteria checks 6/6
AroCell has a total shareholder equity of SEK153.1M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK164.5M and SEK11.4M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr46.35m |
Equity | kr153.14m |
Total liabilities | kr11.40m |
Total assets | kr164.55m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 80R's short term assets (SEK66.0M) exceed its short term liabilities (SEK11.4M).
Long Term Liabilities: 80R has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 80R is debt free.
Reducing Debt: 80R had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 80R has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 80R has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 3.3% each year